NVO
Novo Nordisk A/S
38.20$
-0.2%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures per share in DKK.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.13 | 2.13 | 3.20 | 11.31 | 9.83 | 2.76 | 5.53 | 9.17 | 10.37 | 1.71 | 5.41 | 12.44 | 29.99 | |
| 0.56 | 0.67 | 0.65 | 1.98 | 0.48 | 1.17 | 0.86 | 1.09 | 1.74 | 1.25 | 0.79 | 2.32 | 6.12 | |
| -0.73 | 0.48 | – | – | – | – | – | – | – | – | – | – | – | |
| 0.96 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.60 | -2.16 | -2.15 | 2.21 | -2.53 | 3.05 | -3.69 | 1.07 | -1.12 | 4.58 | -7.47 | 3.00 | -1.01 | |
| 2.37 | 3.67 | 2.02 | 2.96 | 2.80 | 3.71 | 3.28 | 3.66 | 3.47 | 9.86 | 2.71 | 2.89 | 18.96 | |
| -6.50 | -3.29 | 0.88 | -4.64 | -4.69 | -20.45 | -1.50 | -3.20 | -3.47 | -9.63 | -2.63 | -2.88 | -18.65 | |
| 2.99 | 0.00 | 6.39 | 0.00 | 3.49 | 9.90 | 7.93 | 0.04 | 3.75 | 0.06 | 7.94 | 0.00 | 11.78 | |
| -1.37 | -2.18 | -0.63 | -1.67 | -0.54 | -1.68 | -0.31 | -0.01 | -0.01 | 0.00 | -0.54 | -0.79 | -1.34 | |
| -0.06 | – | – | – | -0.09 | 9.94 | 3.45 | -4.41 | -0.10 | 6.62 | 3.31 | -1.65 | 8.21 | |
| -4.42 | -2.26 | -5.90 | 3.74 | -4.13 | 8.26 | 1.23 | -10.40 | -3.84 | 6.62 | -3.92 | -4.31 | -5.45 | |
| 1.85 | -3.46 | -1.80 | 10.41 | 0.94 | -9.27 | 5.24 | -4.61 | 3.07 | -1.26 | -1.20 | 5.27 | 5.87 | |
| 6.76 | -1.54 | 1.19 | 8.35 | 7.03 | -0.95 | 2.25 | 5.51 | 6.90 | -8.14 | 2.71 | 9.56 | 11.03 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.